160 related articles for article (PubMed ID: 31597023)
41. Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
Tedja R; El-Sherief A; Olbrych T; Gordon S
Transpl Infect Dis; 2013 Aug; 15(4):424-9. PubMed ID: 23663268
[TBL] [Abstract][Full Text] [Related]
42. Photo quiz. Generalized pain in a 20-year-old man with chronic granulomatous disease.
Launay E; Thomas C; Gras-Le Guen C; Geffroy L; Moreau A; Lortholary O
Clin Infect Dis; 2013 Aug; 57(4):562-3, 616-7. PubMed ID: 23881728
[No Abstract] [Full Text] [Related]
43. Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.
Gladue HS; Fox DA
J Clin Rheumatol; 2013 Dec; 19(8):444-5. PubMed ID: 24263147
[TBL] [Abstract][Full Text] [Related]
44. Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain.
Moon WJ; Scheller EL; Suneja A; Livermore JA; Malani AN; Moudgal V; Kerr LE; Ferguson E; Vandenberg DM
Clin Infect Dis; 2014 Nov; 59(9):1237-45. PubMed ID: 24992954
[TBL] [Abstract][Full Text] [Related]
45. Voriconazole tolerability in lung transplant recipients: Is N-oxide metabolite responsible for phototoxicity?
Soresi S; Sabashnikov A; Leaver N; Zeriouh M; Simon AR; Popov AF; Carby M
J Heart Lung Transplant; 2015 Oct; 34(10):1354-5. PubMed ID: 26212657
[No Abstract] [Full Text] [Related]
46. Squamous cell carcinoma in an immunosuppressed patient on voriconazole.
Carrascosa R; Solano-López GE; Vargas E; Fraga J
Actas Dermosifiliogr; 2014 May; 105(4):424-6. PubMed ID: 24007811
[No Abstract] [Full Text] [Related]
47. Successful desensitization of voriconazole in an immunosuppressed pediatric patient.
Jean T; Kwong K
J Allergy Clin Immunol Pract; 2015; 3(4):637-8. PubMed ID: 25800818
[No Abstract] [Full Text] [Related]
48. Fluorosis because of prolonged voriconazole therapy in a teenager with acute myelogenous leukemia.
Skiles JL; Imel EA; Christenson JC; Bell JE; Hulbert ML
J Clin Oncol; 2011 Nov; 29(32):e779-82. PubMed ID: 21969513
[No Abstract] [Full Text] [Related]
49. Severe Hyperkalemia Complicating Voriconazole Treatment in a Kidney Transplant Recipient With Histoplasmosis: A Case Report.
Nazmul MN; Miles CD; Westphal SG
Transplant Proc; 2017 Dec; 49(10):2372-2373. PubMed ID: 29198681
[TBL] [Abstract][Full Text] [Related]
50. An adolescent with a skin lesion. Squamous cell carcinoma of the skin secondary to voriconazole-induced photosensitivity.
Smart SE; Crosby T; Jeyakumar A
JAMA Otolaryngol Head Neck Surg; 2014 Oct; 140(10):979-80. PubMed ID: 25188536
[No Abstract] [Full Text] [Related]
51. Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
Trang TP; Hanretty AM; Langelier C; Yang K
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28434195
[TBL] [Abstract][Full Text] [Related]
52. Voriconazole-induced skeletal fluorosis in an allogenic hematopoietic stem cell transplant recipient.
Thekkudan SF; Kumar P; Nityanand S
Ann Hematol; 2016 Mar; 95(4):669-70. PubMed ID: 26820975
[No Abstract] [Full Text] [Related]
53. Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey O; Slavin MA; Stewart K; Kong DC
Med J Aust; 2014 Nov; 201(9):543-4. PubMed ID: 25358582
[No Abstract] [Full Text] [Related]
54. Voriconazole: How to Use This Antifungal Agent and What to Expect.
Malani AN; Kerr LE; Kauffman CA
Semin Respir Crit Care Med; 2015 Oct; 36(5):786-95. PubMed ID: 26398543
[TBL] [Abstract][Full Text] [Related]
55. Severe Polyarthralgia After Kidney Transplant.
Allameen NA; Cho J
JAMA; 2022 Jan; 327(1):77-78. PubMed ID: 34914821
[No Abstract] [Full Text] [Related]
56. Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.
Kolaitis NA; Duffy E; Zhang A; Lo M; Barba DT; Chen M; Soriano T; Hu J; Nabili V; Saggar R; Sayah DM; DerHovanessian A; Shino MY; Lynch JP; Kubak BM; Ardehali A; Ross DJ; Belperio JA; Elashoff D; Saggar R; Weigt SS
Transpl Int; 2017 Jan; 30(1):41-48. PubMed ID: 27678492
[TBL] [Abstract][Full Text] [Related]
57. Voriconazole-associated phototoxic dermatoses and skin cancer.
Goyal RK
Expert Rev Anti Infect Ther; 2015; 13(12):1537-46. PubMed ID: 26488688
[TBL] [Abstract][Full Text] [Related]
58. Voriconazole-induced periostitis.
Rossier C; Dunet V; Tissot F; Aubry-Rozier B; Marchetti O; Boubaker A
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):375-6. PubMed ID: 21894545
[No Abstract] [Full Text] [Related]
59. Efficacy and safety of voriconazole in immunocompromised patients: systematic review and meta-analysis.
Rosanova MT; Bes D; Serrano Aguilar P; Sberna N; Lede R
Infect Dis (Lond); 2018 Jul; 50(7):489-494. PubMed ID: 29262742
[TBL] [Abstract][Full Text] [Related]
60. Voriconazole Dosing in Children Younger Than 3 Years Undergoing Cancer Chemotherapy or Hematopoietic Stem Cell Transplantation.
Yan SQ; Seyboth B; Kobos R; Eaton A; Seo SK; Cohen N
J Pediatric Infect Dis Soc; 2018 May; 7(2):169-171. PubMed ID: 28407118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
